Animal experiments were performed according to accepted standards of animal welfare and with the permission of the authorities of Thüringen. Estrogen treatment was given for four weeks by subcutaneous implantation of slow-release pellets resulting in a calculated dose of 0.24 mg/kg/d (0.36 mg; 60-day release; Innovative Research of America, Inc.) in 10-12 week old female C57BL/6 or CD45.1 (wild-type) mice and in ERα-and ERβ-knockout, ERα−loxP Runx2Cre mice. 7-10 Mice received short-term treatment with estradiol 5 mg/kg (Sigma) i.p. daily.
Bone sections and von Kossa stainingLumbar vertebral bodies (L3-L5) and one tibia of each mouse were processed and stained, and bone histomorphometry was performed, all as previously described.
9Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone August 5, 2011. Revised version arrived on January 25, 2012. Manuscript accepted on February 13, 2012 Fax: international +49.731.5022581. Hematopoietic stem and progenitor cells reside in vascular and endosteal niches in the bone marrow. Factors affecting bone remodeling were reported to influence numbers and mobilization of hematopoietic stem cells. We therefore analyzed the effects of estradiol acting anabolic on bone integrity. Here we observe that estradiol increases progenitor cell numbers in the vascular but not in the endosteal compartment independent of its estrogen receptor α-dependent anabolic bone effects. Hematopoietic progenitors capable of reconstituting lethally irradiated mice are increased by enhanced cell cycle entry, leading to a diminished long-term reconstitution potential after serial transplantation. We demonstrate that estradiol action on stromal cells potently favors hematopoietic progenitor/stem cell frequency accompanied by enhanced expression of cell adhesion molecules. Finally, estradiol treatment enhances retention of hematopoietic stem cells in the vascular niche of the bone marrow. We describe for the first time the mechanism of estrogen action on hematopoietic stem and progenitor cells. Haematologica 2012;97(8): 1131-1135. doi:10.3324/haematol.2011 This is an open-access paper.
ABSTRACT
© F e r r a t a S t o r t i F o u n d a t i o n
Isolation of hematopoietic cells of the vascular and endosteal nicheThe flushed fraction of the BM from hindlimbs and humeri represents the cells from the vascular niche. Endosteal BM cells were isolated as previously described. 11 The digested fraction represents the cells of the endosteal niche.
Flow cytometryFlow cytometry was performed as described.12 Monoclonal antibodies from Natutec /eBioscience were:Gr1-FITC, B220-FITC, CD3-FITC, CD11b-FITC, Ter119-FITC, Sca1-PE,CD117-APC, CD150-PE, CD150-APC, CD48-PE, CD48-APC, CD45.1-FITC, B220-PE, Gr1-PE, CD11b-APC, CD4-PE, CD8-APC.Data were recorded with FACS-Canto II or FACS-Calibur (BDBiosciences) and analyzed by Flow Jo 8.0 flow cytometry software (Tristar).
CAFC assayCobblestone area forming cell (CAFC) assay was performed as described 13 and frequency of HSC was calculated us...